Insider Trading Alert - GIMO, KMG And JBSS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, April 30, 2015, 53 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $10.00 to $250,000,000.60.

Highlighted Stocks Traded by Insiders:

Gigamon (GIMO) - FREE Research Report

Merchant Shehzad, who is Chief Technology Officer at Gigamon, sold 10,000 shares at $30.00 on April 30, 2015. Following this transaction, the Chief Technology Officer owned 74,855 shares meaning that the stake was reduced by 11.78% with the 10,000-share transaction.

The shares most recently traded at $29.59, down $0.41, or 1.39% since the insider transaction. Historical insider transactions for Gigamon go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 1,500
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 2,631
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 11,857

The average volume for Gigamon has been 392,200 shares per day over the past 30 days. Gigamon has a market cap of $987.7 million and is part of the technology sector and computer hardware industry. Shares are up 67.91% year-to-date as of the close of trading on Thursday.

Gigamon Inc. designs, develops, and sells products and services that provide customers with visibility and control of network traffic for enterprises and services providers in the United States, rest of Americas, Europe, the Middle East, Africa, and the Asia Pacific. Currently, there are 4 analysts who rate Gigamon a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GIMO - FREE

TheStreet Quant Ratings rates Gigamon as a sell. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity. Get the full Gigamon Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

KMG Chemicals (KMG) - FREE Research Report

Hatcher David L, who is 10% Owner at KMG Chemicals, sold 1,500 shares at $30.74 on April 30, 2015. Following this transaction, the 10% Owner owned 2.0 million shares meaning that the stake was reduced by 0.08% with the 1,500-share transaction.

The shares most recently traded at $29.88, down $0.86, or 2.88% since the insider transaction. Historical insider transactions for KMG Chemicals go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 22,500
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 27,500
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 27,500

The average volume for KMG Chemicals has been 60,900 shares per day over the past 30 days. KMG Chemicals has a market cap of $361.8 million and is part of the basic materials sector and chemicals industry. Shares are up 54.85% year-to-date as of the close of trading on Thursday.

KMG Chemicals, Inc., through its subsidiaries, engages in the manufacture, formulation, and distribution of specialty chemicals in the United States, Mexico, Canada, Europe, Israel, and Singapore. It operates in two segments, Electronic Chemicals and Wood Treating Chemicals. The stock currently has a dividend yield of 0.39%. The company has a P/E ratio of 51.6. Currently, there is 1 analyst who rates KMG Chemicals a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KMG - FREE

TheStreet Quant Ratings rates KMG Chemicals as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full KMG Chemicals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

John B Sanfilippo & Son (JBSS) - FREE Research Report

Edgar Jim, who is Director at John B Sanfilippo & Son, sold 6,000 shares at $51.12 on April 30, 2015. Following this transaction, the Director owned 16,646 shares meaning that the stake was reduced by 26.49% with the 6,000-share transaction.

The shares most recently traded at $51.40, up $0.28, or 0.55% since the insider transaction. Historical insider transactions for John B Sanfilippo & Son go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 4,750
  • 24-Week # shares sold: 9,075

The average volume for John B Sanfilippo & Son has been 65,300 shares per day over the past 30 days. John B Sanfilippo & Son has a market cap of $456.6 million and is part of the consumer goods sector and food & beverage industry. Shares are up 17.65% year-to-date as of the close of trading on Thursday.

John B. Sanfilippo & Son, Inc., together with its subsidiaries, processes and distributes peanuts and tree nuts in the United States. The company has a P/E ratio of 21.9. Currently, there are no analysts who rate John B Sanfilippo & Son a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JBSS - FREE

TheStreet Quant Ratings rates John B Sanfilippo & Son as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full John B Sanfilippo & Son Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing